Frontlight ResearchEarly access
WithdrawnNo phase
Lung Function Outcomes Following Removal of Airway Mucus Plugs in Patients With Asthma (FOCUS)
Key facts
- Who runs it
- University of California, San Francisco
- Where
- San Francisco, United StatesSee the site
- Trial code
- Status
- Withdrawn
- Started
- 26 Jan 2022
- Ended
- 25 Mar 2025
- Type of study
- Interventional
- Treatments tested
- Therapeutic bronchoscopy for removal of mucus plugs
- Record updated
- 13 January 2026
- Why it stopped
- No participants were enrolled in protocol A due to COVID-related restrictions and funding issues.
Who can take part
- Age
- 18 years to 80 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
Show the full registry criteria (21)Hide the full registry criteria
Who can take part
- Males or females between the ages 18 to 70 at the time of visit 1
- Clinical history of asthma per patient report or medical record
- Pre-bronchodilator FEV1 < 80% predicted and ≥ 35% predicted
- CT mucus plug score > 5
- Written informed consent obtained from subject and ability for subject to comply with the requirements of the study
- Males or females between the ages 18 to 80 at the time of visit 1
- Undergoing clinically indicated bronchoscopy for removal of mucus plugs
- Clinical history of airway disease (including asthma, COPD and bronchiectasis) per patient report or medical record
- Written informed consent obtained from subject
Who cannot take part
- Current use of anticoagulant medications
- Upper Respiratory Infection (URI) within the previous 6 weeks
- History of other pulmonary disorders including cystic fibrosis and COPD (Chronic Obstructive Pulmonary Disease)
- History of unstable cardiovascular disease
- History of COVID-19 (coronavirus disease) in the past 6 months; Protocol B:
- Upper Respiratory Infection (URI) in the past 30 days
- History of COVID-19 in the past 30 days
- Smoking of tobacco or other recreational inhalants in the last month and/or >10 pack-year smoking history
- BMI > 45
- Currently pregnant and/or unwillingness to practice medically acceptable birth control or complete abstinence during the study
- Currently pregnant during the study
Other criteria
- Protocol A:
Where in United States
- UCSF Airway Clinical Research CenterSan Francisco, United States
About the trial
What the trial wants to find out
This is a single-center study that will evaluate the safety and tolerability of removal of mucus plugs by bronchoscopy in patients with asthma. This protocol will also plan for the analysis of the features of the mucus plugs removed.
The group in the trial
- Therapeutic bronchoscopy for removal of mucus plugsTreatment being tested
Protocol A: This protocol will study 10 patients with asthma who have CT (Computed Tomography) evidence of mucus plugs in their airways. Screening data will be reviewed to determine participant eligibility. Participants who meet all eligibility criteria will participate in a bronchoscopy done on one lung for the first 5 participants, and if single lung mucus removal is well tolerated then we will perform bronchoscopies on both lungs for the next 5 participants.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Lung Function Outcomes Following Removal of Airway Mucus Plugs in Patients With Asthma
- Record updated
- 13 January 2026